×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments
Yahoo Finance
Phase 3 portion of Orbit Study and Phase 3 Cosmic Study of setrusumab for treatment of Osteogenesis Imperfecta (OI) conducted by partner...
4 months ago
Needham & Company LLC Reiterates “Buy” Rating for Mereo BioPharma Group (NASDAQ:MREO)
Defense World
Read Needham & Company LLC Reiterates “Buy” Rating for Mereo BioPharma Group (NASDAQ:MREO) at Defense World.
1 day ago
Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
LONDON, May 15, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage...
6 days ago
Cantor Fitzgerald Analysts Cut Earnings Estimates for Mereo BioPharma Group plc (NASDAQ:MREO)
MarketBeat
Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) - Research analysts at Cantor Fitzgerald cut their FY2024 earnings estimates for...
1 day ago
Mereo's Pipeline Promise Vs. Valuation And Market Realities (NASDAQ:MREO)
Seeking Alpha
It is focused on developing and distributing novel treatments for cancer and rare diseases. Today, MREO is mostly a bet on its flagship drugs,...
1 month ago
Equities Analysts Offer Predictions for Mereo BioPharma Group plc's Q2 2024 Earnings (NASDAQ:MREO)
Defense World
Mereo BioPharma Group plc (NASDAQ:MREO – Free Report) – Equities researchers at Leerink Partnrs issued their Q2 2024 earnings per share...
1 day ago
Ultragenyx and Mereo's genetic bone disease treatment cuts fractures by 67%
Fierce Biotech
New data from Ultragenyx and Mereo found their brittle bone disease treatment reduced the rate of fractures by two-thirds.
7 months ago
Alpha-1 Antitrypsin Deficiency Market to Register Incremental Growth by 2032, Assesses DelveInsight | Key ...
PR Newswire
PRNewswire/ -- DelveInsight's Alpha-1 Antitrypsin Deficiency Market Insights report includes a comprehensive understanding of current...
4 months ago
FY2024 Earnings Estimate for Mereo BioPharma Group plc Issued By Leerink Partnrs (NASDAQ:MREO)
MarketBeat
Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) - Leerink Partnrs increased their FY2024 earnings estimates for shares of Mereo...
4 days ago
Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - 15.05.2024
Wallstreet Online
15.05.2024 - LONDON, May 15, 2024 (GLOBE NEWSWIRE) - Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage...
6 days ago